Rena Therapeutics specializes in developing cutting-edge gene therapy solutions aimed at treating rare genetic disorders. The company operates in the biotechnology sector, focusing on advanced genome editing technologies to create effective treatments. Rena Therapeutics primarily serves patients suffering from rare diseases, collaborating with healthcare providers and research institutions to bring innovative therapies to market. The business model revolves around research and development, clinical trials, and eventual commercialization of gene therapies. Revenue is generated through partnerships, licensing agreements, and sales of approved therapies.

Keywords: gene therapy, rare diseases, genome editing, biotechnology, healthcare, R&D, clinical trials, commercialization, partnerships, licensing.